SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ciphergen Biosystems(CIPH):
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Biomaven who wrote (360)8/8/2005 3:07:53 AM
From: tuck  Read Replies (1) of 510
 
There's also the issue of ELISA using much more sample, though that is more important factor in the discovery phase than in the screening phase. But here's the SELDI advantage over ELISA as summarized by Petricoin:

"Mass spectroscopy as a clinical analytical method has many unique attributes that no ELISA can achieve at this time. In addition to the speed of mass spectroscopy, ions can be precisely identified without the need for antibody development or a priori amino acid sequencing. This agnostic approach affords the experimentalist an approach to disease detection without bias about the source or identity of the markers. Mass spectroscopy can differentiate clipped or modified versions of molecules with extremely high speed and resolution. If the biomarker were a cleaved version of a larger, abundant protein, it may be nearly impossible to generate antibodies that recognize the cleaved version and do not cross-react with the much more abundant parent species. Consequently, mass spectroscopy is attractive for biomarker discovery as well as routine high-throughput testing."

Emphasis mine. From:

clinchem.org

Isoform specific ELISAs are out there, at least for some proteins. But fragments seem to be a weakness for ELISA. The TTR fragment in question has had the N-terminal lopped off.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News